Oncolytics Biotech CEO Shares Insight on Viral-Based Immunology and Cancer Treatments

April 9, 2015 1:21 PM

7 0

Brad Thompson is the CEO of Oncolytics Biotech. Recently, when the CBS Show “60 Minutes” covered a story regarding virus-based cancer treatments, he expressed great joy. It is not often that news reports discuss innovative treatments like, for example, how Duke University researchers engineered a polio virus to treat glioblastoma (a most deadly form of brain cancer).

But Thompson also expressed concern that these stories kind of just pique some interest and perhaps even inspire a little excitement only to disappear after a while.

Read more

To category page